Acadia Pharmaceuticals buy Robert W. Baird
Start price
19.05.25
/
50%
€19.56
Target price
19.05.26
€27.74
Performance (%)
-10.43%
End price
20.05.26
€17.52
Summary
This prediction ended on 20.05.26 with a price of €17.52. The price of Acadia Pharmaceuticals has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.43%. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Acadia Pharmaceuticals | 2.316% | 2.316% | 21.379% |
| iShares Core DAX® | -0.874% | 5.325% | 6.865% |
| iShares Nasdaq 100 | -0.381% | 1.979% | 25.696% |
| iShares Nikkei 225® | -1.676% | 1.952% | 41.443% |
| iShares S&P 500 | -0.655% | 2.069% | 21.405% |
Comments by Robert_W__Baird for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target raised by analysts at Robert W. Baird from $28.00 to $31.00. They now have an "outperform" rating on the stock.
Ratings data for ACAD provided by MarketBeat
In the thread Trading Acadia Pharmaceuticals
Die von Robert_W__Baird gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Robert_W__Baird for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€15.02
09.05.24
09.05.24
€26.02
09.05.25
09.05.25
5.19%
10.05.25
10.05.25
